EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review

Sapna Ravindranath iD, Kevin Backfish-White, John Wolfe iD, Yatish S Ranganath iD

Journal of Clinical Medicine · 11.06.2025 · 14 (12) · 4128

DOI: 10.3390/jcm14124128 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.06.2025. Verfasst von Sapna Ravindranath und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Anesthesiology at Indiana University School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sugammadex represents a significant advancement in neuromuscular blockade management, enabling rapid, predictable, and highly effective reversal of steroidal neuromuscular blockers such as rocuronium and vecuronium. This review critically examines recent advances in sugammadex research, particularly over the last decade, detailing its pharmacological profile, clinical efficacy, and safety compared to traditional reversal agents, like neostigmine. Its expanding clinical applications across operating rooms, critical care units, and emergency medicine are discussed, emphasizing dosing recommendations and clinical utility in special patient populations, including individuals with renal impairment, pediatric, obstetric, and obese patients. Economic considerations are explored, highlighting sugammadex’s cost-effectiveness through reduced postoperative complications and enhanced operational efficiency, despite higher initial costs. Finally, the review outlines ongoing research directions, including emerging reversal agents, advanced neuromuscular monitoring technologies, and potential future clinical applications, underscoring sugammadex’s evolving role in improving patient safety and anesthetic practice.

Schlagwörter

Stichwörter der Autor:innen

Vecuronuimneostigmineneuromuscular blockade reversalneuromuscular monitoringresidual paralysisrocuroniumsugammadex

Autor:innen und Institutionen

  • Department of Anesthesia, Indiana University School of Medicine, Indianapolis, IN 46202, USA.

ORCID-Profile: Sapna Ravindranath, John Wolfe, Yatish S Ranganath

Förderung

  • Department of Anesthesiology at Indiana University School of Medicine

Zitieren

APA

Ravindranath, S., Backfish-White, K., Wolfe, J., & Ranganath, Y. S. (2025). Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review. Journal of Clinical Medicine, 14(12), 4128. https://doi.org/10.3390/jcm14124128

Vancouver

Ravindranath S, Backfish-White K, Wolfe J, Ranganath YS. Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review. Journal of Clinical Medicine. 2025;14(12):4128. doi:10.3390/jcm14124128

BibTeX
@article{Ravindranath2025,
  author = {Ravindranath, Sapna and Backfish-White, Kevin and Wolfe, John and Ranganath, Yatish S},
  title = {Sugammadex for Neuromuscular Blockade Reversal: A Narrative Review},
  journal = {Journal of Clinical Medicine},
  year = {2025},
  volume = {14},
  number = {12},
  pages = {4128},
  doi = {10.3390/jcm14124128}
}
Kostenlos starten →